E-Pharma Market - Forecasts from 2019 to 2024

May 2019 | 106 pages | ID: E17C15AE1CC0EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global e-pharma market is projected to grow at a CAGR of 19.3% to reach US$72,694 million by 2024, from US$25,212 million in 2018. With rapid internet penetration across the global economy, the adoption of e-commerce model and digital technologies to the pharmaceutical industry is going to be a big game changer in the pharmaceutical markets across the globe. Increasing demand for common drugs, increasing rate of ingestion of medicines, growth in efficient manufacturing technologies and aging population are some of the factors intensely propelling the e-Pharma industry all over the globe. Europe and North America hold big shares in the market and emerging markets in Asia-Pacific have been showing a high growth rate. This fast growth can be attributed to the availability of skilled labor force and lower labor costs in these markets. However, dealing with stringent government regulations and controlling the sale of unapproved and counterfeit medicines will be some of the challenges this industry is going to face in the coming years.

DRIVERS

Growing demand for healthcare products and medicines with the aging population having unmet healthcare needs.

Investments in this sector by many players in fastest growing economies like India and China with high internet penetration.

RESTRAINTS

Illegal ePharmacies selling unapproved and counterfeit medicines will make some consumers skeptical.

Full internet connectivity and robust infrastructure is still a supply-side issue in emerging markets where demand is high

RECENT DEVELOPMENTS

Many firms are going for contract service providers for vertical integration.

In some firms, there is an effort to set up a symbiotic relationship with coordinated suppliers by major players.

Procurements and Incorporation are strategies many key players are using.

Several new e-Pharmacy start-ups are coming up in emerging economies like India and China attracting significant funding.

Segmentation

The global e-pharma market has been analyzed through the following segments:

By Type

Prescription

Non-Prescription

By Geography

North America

USA

Canada

Others

South America

Brazil

Argentina

Others

Europe

Germany

United Kingdom

France

Others

Middle East and Africa

Israel

UAE

Saudi Arabia

Others

Asia Pacific

China

South Korea

Japan

India

Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL E-PHARMA MARKET BY TYPE

5.1. Prescription
5.2. Non-Prescription

6. GLOBAL E-PHARMA MARKET BY GEOGRAPHY

6.1. North America
  6.1.1. USA
  6.1.2. Canada
  6.1.3. Others
6.2. South America
  6.2.1. Brazil
  6.2.2. Argentina
  6.2.3. Others
6.3. Europe
  6.3.1. Germany
  6.3.2. United Kingdom
  6.3.3. France
  6.3.4. Spain
  6.3.5. Others
6.4. Middle East and Africa
  6.4.1. Israel
  6.4.2. UAE
  6.4.3. Saudi Arabia
  6.4.4. Others
6.5. Asia Pacific
  6.5.1. China
  6.5.2. South Korea
  6.5.3. Japan
  6.5.4. India
  6.5.5. Others

7. COMPETITIVE INTELLIGENCE

7.1. Competitive Benchmarking and Analysis
7.2. Recent Investments and Deals
7.3. Strategies of Key Players

8. COMPANY PROFILES

8.1. Walmart Stores Inc.
8.2. Walgreen Co.
8.3. Rowlands Pharmacy
8.4. DocMorris
8.5. Pfizer CentreSource
8.6. The Kroger Co.
8.7. Express Scripts Holding Company
8.8. OptumRx Inc.
8.9. CVS Health
LIST OF FIGURES
LIST OF TABLES